Cover Image
市場調查報告書

ACROVIS biostructures GmbH:產品平台分析

ACROVIS biostructures GmbH - Product Pipeline Review - 2014

出版商 Global Markets Direct 商品編碼 318947
出版日期 內容資訊 英文 16 Pages
訂單完成後即時交付
價格
Back to Top
ACROVIS biostructures GmbH:產品平台分析 ACROVIS biostructures GmbH - Product Pipeline Review - 2014
出版日期: 2014年11月14日 內容資訊: 英文 16 Pages
簡介

ACROVIS biostructures GmbH是致力於研究開發非常創新的營養食品之製藥公司。該公司的產品有保持男性正常性功能的補給品,還有組合特殊微量營養素,對關節功能有效的補給品等。

本報告提供ACROVIS biostructures GmbH的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

ACROVIS biostructures GmbH的基本資料

  • ACROVIS biostructures GmbH概要
  • 主要資訊
  • 企業資料

ACROVIS biostructures GmbH:R&D概要

  • 主要的治療範圍

ACROVIS biostructures GmbH:開發平台的評估

  • 各開發階段的開發中產品
  • 單劑產品

ACROVIS biostructures GmbH:開發中產品概況

  • 初期階段的開發中產品
    • 藥物研發中的產品/聯合治療模式

ACROVIS biostructures GmbH:藥物簡介

  • ACR-488
  • Small Molecules for Acute Renal Failure
  • Small Molecules for Liver Diseases

ACROVIS biostructures GmbH:開發平台分析

  • 各分子類型

ACROVIS biostructures GmbH:總公司和子公司的所在地

附錄

圖表

目錄
Product Code: GMDHC06502CDB

Summary

Global Markets Direct's, 'ACROVIS biostructures GmbH - Product Pipeline Review - 2014', provides an overview of the ACROVIS biostructures GmbH's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of ACROVIS biostructures GmbH's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of ACROVIS biostructures GmbH including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of ACROVIS biostructures GmbH's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the ACROVIS biostructures GmbH's pipeline products

Reasons to buy

  • Evaluate ACROVIS biostructures GmbH's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of ACROVIS biostructures GmbH in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the ACROVIS biostructures GmbH's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of ACROVIS biostructures GmbH and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of ACROVIS biostructures GmbH
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of ACROVIS biostructures GmbH and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • ACROVIS biostructures GmbH Snapshot
    • ACROVIS biostructures GmbH Overview
    • Key Information
    • Key Facts
  • ACROVIS biostructures GmbH - Research and Development Overview
    • Key Therapeutic Areas
  • ACROVIS biostructures GmbH - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • ACROVIS biostructures GmbH - Pipeline Products Glance
    • ACROVIS biostructures GmbH - Early Stage Pipeline Products
      • Discovery Products/Combination Treatment Modalities
  • ACROVIS biostructures GmbH - Drug Profiles
    • ACR-488
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules for Acute Renal Failure
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules for Liver Diseases
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • ACROVIS biostructures GmbH - Pipeline Analysis
  • ACROVIS biostructures GmbH - Pipeline Products by Molecule Type
  • ACROVIS biostructures GmbH - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • ACROVIS biostructures GmbH, Key Information
  • ACROVIS biostructures GmbH, Key Facts
  • ACROVIS biostructures GmbH - Pipeline by Indication, 2014
  • ACROVIS biostructures GmbH - Pipeline by Stage of Development, 2014
  • ACROVIS biostructures GmbH - Monotherapy Products in Pipeline, 2014
  • ACROVIS biostructures GmbH - Discovery, 2014
  • ACROVIS biostructures GmbH - Pipeline by Molecule Type, 2014

List of Figures

  • ACROVIS biostructures GmbH - Pipeline by Top 10 Indication, 2014
Back to Top